UnitedHealth to Buy Catamaran
UnitedHealth Group plans to buy Catamaran for about $12.8
billion in cash, bulking up its pharmacy-benefit business.
Catamaran shares up 25% premarket; UnitedHealth up 2%.
Teva to Acquire Auspex in $3.2 Billion Deal
Teva Pharmaceutical Industries agreed to acquire Auspex
Pharmaceuticals in a deal valued at roughly $3.2 billion,
increasing its presence in market for treatments for central
nervous system disorders. Auspex shares up 41% premarket.
Horizon Pharma to Buy Hyperion Therapeutics
Horizon Pharma has agreed to purchase Hyperion Therapeutics for
$955.7 million in cash, in a move to expand its drug portfolio by
adding two treatments for a rare metabolic condition.
AIG Raising Up to $507M in PICC Property & Casualty Sale
American International Group is raising up to US$507 million by
selling shares in PICC Property & Casualty in an share
placement, according to a term sheet seen by The Wall Street
Journal.
EU OKs Biomet-Zimmer Deal, Subject to Asset Sales
Zimmer Holdings secured approval in the European Union for its
$13 billion acquisition of fellow orthopedic-device maker Biomet
after agreeing to sell three businesses in Europe to assuage
antitrust concerns.
U.K.'s Biggest Banks Undergo Stress Test
The U.K.'s biggest banks will be subjected to a severe global
economic slowdown and face major difficulty trading assets under
the latest Bank of England stress test.
Holcim Shareholder Plans to Vote Against Lafarge Deal
Eurocement Holding, the second-largest shareholder in cement
company Holcim, plans to vote against the Swiss company's union
with Lafarge unless the financial terms of the deal are altered,
according to a person familiar with situation.
EIG to Invest in Breitburn
EIG Global Energy Partners agreed to invest $1 billion in
Breitburn Energy Partners, a publicly traded oil and gas
exploration and production company, as energy producers turn to
alternative capital sources to bolster their balance sheets.